Skip to main content

Cybin Inc(CYBN-A)
NYSE Arca

Today's Change
Delayed Last Update

Cybin Inc

100 KING STREET WEST SUITE 5600
TORONTO A6 M5X 1C9 CAN
P: 908-764-8385
http://www.cybin.com

Sectors & Indices

Sector
Industry
Employees

    Profile

    Cybin Inc. is a biotechnology company. It is focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders. Cybin Inc. is based in Toronto, Canada.

    Key Executives

    NameTitle
    Information not available.

    More from The Globe

    opinion
    Why are Canadian bank valuations so low?
    Tom Bradley
    number cruncher
    Eleven U.S. semiconductor stocks showing strength
    For Number Cruncher column in Globe Investor/ROB only.
    Wednesday’s analyst upgrades and downgrades
    An office building for Goeasy Ltd, a personal lender for subprime borrowers, in Mississauga, Ontario, on March 10, 2026.
    Bullish on Archer-Daniels-Midland Co.
    Monica Rizk
    Constellation ‘well-positioned’ to tackle AI disruption in software industry, company president says
    In this photo illustration, a mobile phone with the logo of Canadian company Constellation Software Inc. is seen in front of business website.
    number cruncher
    Eight telecom stocks to watch during volatile times
    For Number Cruncher column in Globe Investor/ROB only.
    The most oversold and overbought stocks on the TSX
    The TMX Market Centre is shown in Toronto, Wednesday, Sept. 11, 2024.
    Small caps to watch: Aecon, Maple Leaf Foods, Tecsys and more
    Packages of Maple Leaf Foods chicken breasts are shown on a shelf at a grocery store in Oakville, Ont., Friday, Jan.6, 2023.

    All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

    Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

    Financial data provided by Zacks Investment Research.